By: Benzinga
Tranzyme Pharma Names David Moore Chief Business Officer
Tranzyme Pharma (NASDAQ: TZYM ) today announced that David S. Moore has been named as Chief Business Officer. "Dave has provided meaningful contributions and leadership since joining Tranzyme said Vipin Garg, PhD, Tranzyme's President and Chief Executive Officer. I look forward to working with him in his new role as
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here